Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Barriers to Implementation of Optimal Laboratory Biosafety Practices in Pakistan.

Shakoor S, Shafaq H, Hasan R, Qureshi SM, Dojki M, Hughes MA, Zaidi AK, Khan E.

Health Secur. 2016 Jul-Aug;14(4):214-9. doi: 10.1089/hs.2016.0031. Epub 2016 Jul 11.

2.

Knowledge and practices of laboratory workers on standardized antimicrobial susceptibility testing and biosafety practices to prevent the spread of superbugs in Pakistan.

Ghanchi NK, Khan E, Farooqi JQ, Fasih N, Dojki M, Hughes MA.

Am J Infect Control. 2014 Sep;42(9):1022-4. doi: 10.1016/j.ajic.2014.06.006.

PMID:
25179341
3.

Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.

Hasan Z, Jamil B, Ashraf M, Islam M, Dojki M, Irfan M, Hussain R.

Clin Vaccine Immunol. 2009 Jul;16(7):991-8. doi: 10.1128/CVI.00091-09. Epub 2009 May 13.

5.

Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population.

Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, Mehmood H, Dawood G, Dockrell HM.

J Immunol Methods. 2002 Jun 1;264(1-2):95-108.

PMID:
12191514
7.

Induction of Th1 cytokine responses by mycobacterial antigens in leprosy.

Dockrell HM, Young SK, Britton K, Brennan PJ, Rivoire B, Waters MF, Lucas SB, Shahid F, Dojki M, Chiang TJ, Ehsan Q, McAdam KP, Hussain R.

Infect Immun. 1996 Oct;64(10):4385-9.

8.

Supplemental Content

Support Center